BIOLINERX SP ADR (NQ:BLRX)
Delayed: 1.78 --0 (-0%)
Trade Now!
Previous Close $1.78    52 Week High $5.10 
Open $1.76    52 Week Low $1.59 
Day High $1.79    P/E N/A 
Day Low $1.71    EPS $0.00 
Volume 54,350       

Friends, Peers and Foes (?): ORMP (more...)

May 17, 2013 04:20 PM Form 6-K BioLineRx Ltd. For: May 17
May 17, 2013 12:01 PM BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
May 17, 2013 12:00 PM BioLineRx Enters into “At-The-Market” Offering Agreement with Stifel, Nicolaus & Company
May 9, 2013 07:00 AM BioLineRx to Present at the Oppenheimer 14th Annual Israeli Conference on May 12th
May 7, 2013 07:02 AM Form 6-K BioLineRx Ltd. For: May 07
May 7, 2013 07:00 AM BioLineRx Reports First Quarter 2013 Results
May 2, 2013 12:20 PM BioLineRx's BL-7010, for the Treatment of Celiac, to be Presented at Two Leading Conferences
Apr 30, 2013 07:01 AM Form 6-K BioLineRx Ltd. For: Apr 30
Apr 30, 2013 07:00 AM BioLineRx to Report First Quarter 2013 Results on May 7, 2013
Apr 29, 2013 07:16 AM BioLineRx (BLRX) Enrolls First Patients in BL-8020 Phase I/II as HCV Treatment
View All Articles

Entities mentioned with BLRX

View All Entities